Genotype-related Drug Metabolism Completed Phase 1 Trials for Talinolol (DB11770)

IndicationStatusPhase
DBCOND0062265 (Genotype-related Drug Metabolism)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01788254Open Label Study for the Functional Characterization of Drug Metabolism and TransportBasic Science